KDnuggets : News : 2001 : n18 : item24    (previous | next)

Briefs

X-Miner 1.0 Computational Platform for Predictive Medicine and Diagnostics
HAYWARD, Calif.--(BW HealthWire)--Aug. 24, 2001

X-MINE Inc today introduced X-Miner(TM) 1.0, the company's leading
computational platform for genomic data mining. X-Miner(TM) 1.0
constitutes major advances in data computation and pattern
recognition. X-Miner 1.0 combines leading approaches from modern
statistics, pattern recognition, and hi-performance parallel computing
into a seamlessly integrated platform for genomics and proteomics.

"X-Miner 1.0 represents a big leap forward in the speed, precision,
and expertise needed to unlock value from genomic data," said Sandip
Ray, President and CEO of X-MINE. "X-Mine tools are applicable to a
broad range of biological queries including disease mechanism, target
function, prediction of drug mechanism of action, biological efficacy,
small molecule screen analysis, clinical profiling, and predictive
toxicology. And they are in principal customizable for data emerging
from mass spec, protein chips and SNPs."

X-MINER(TM) 1.0, is the first computational platform to provide the
most expansive suite of hi-performance molecular pattern recognition
software applications focused on supervised prediction and discovery
for gene expression. Supervised tools are unique in their ability to
predict outcomes with the support of a supervising vector that is
derived from gene, tissue, survival time, drug, or other pre-existing
information.

Founded by leaders in the field of genomics from MIT/ Whitehead
Institute and Stanford University, X-Mine is a genomic knowledge
discovery company. X-Mine offers products and partnerships in
molecular pattern recognition, information refinement, and knowledge
expertise for predictive medicine and diagnostics. X-Mine products and
partnerships address the single largest cost issue in drug discovery
and development, namely, validation of product candidates early in the
development process, enabling researchers to devote valuable time and
resources for development of products most likely to impart real
benefit for disease, in a reduced timeframe.

For more information about X-Mine please visit http://www.x-mine.com


KDnuggets : News : 2001 : n18 : item24    (previous | next)

Copyright © 2001 KDnuggets.   Subscribe to KDnuggets News!